Arun B - Search Results

1

A Surge of DNA Damage Links Transcriptional Reprogramming and Hematopoietic Deficit in Fanconi Anemia.

Shen X, Wang R, Kim MJ, Hu Q, Hsu CC, Yao J, Klages-Mundt N, Tian Y, Lynn E, Brewer TF, Zhang Y, Arun B, Gan B, Andreeff M, Takeda S, Chen J, Park JI, Shi X, Chang CJ, Jung SY, Qin J, Li L. Shen X, et al. Among authors: arun b. Mol Cell. 2020 Dec 17;80(6):1013-1024.e6. doi: 10.1016/j.molcel.2020.11.040. Mol Cell. 2020. PMID: 33338401 Free PMC article.

2

Targeting Aberrant p70S6K Activation for Estrogen Receptor-Negative Breast Cancer Prevention.

Wang X, Yao J, Wang J, Zhang Q, Brady SW, Arun B, Seewaldt VL, Yu D. Wang X, et al. Among authors: arun b. Cancer Prev Res (Phila). 2017 Nov;10(11):641-650. doi: 10.1158/1940-6207.CAPR-17-0106. Epub 2017 Sep 6. Cancer Prev Res (Phila). 2017. PMID: 28877935 Free PMC article.

3

Tissue transglutaminase-induced alterations in extracellular matrix inhibit tumor invasion.

Mangala LS, Arun B, Sahin AA, Mehta K. Mangala LS, et al. Among authors: arun b. Mol Cancer. 2005 Sep 9;4:33. doi: 10.1186/1476-4598-4-33. Mol Cancer. 2005. PMID: 16153302 Free PMC article.

4

Clinical outcome and toxicity from taxanes in breast cancer patients with BRCA1 and BRCA2 pathogenic germline mutations.

Bayraktar S, Zhou JZ, Bassett R, Gutierrez Barrera AM, Layman RM, Valero V, Arun B. Bayraktar S, et al. Among authors: arun b. Breast J. 2020 Aug;26(8):1572-1582. doi: 10.1111/tbj.13922. Epub 2020 Jun 4. Breast J. 2020. PMID: 32497289

5

Silencing kinase-interacting stathmin gene enhances erlotinib sensitivity by inhibiting Ser¹⁰ p27 phosphorylation in epidermal growth factor receptor-expressing breast cancer.

Zhang D, Tari AM, Akar U, Arun BK, LaFortune TA, Nieves-Alicea R, Hortobagyi GN, Ueno NT. Zhang D, et al. Mol Cancer Ther. 2010 Nov;9(11):3090-9. doi: 10.1158/1535-7163.MCT-10-0362. Epub 2010 Nov 2. Mol Cancer Ther. 2010. PMID: 21045138 Free PMC article.

6

Clinical implications of breast cancer tumor genomic testing.

Damodaran S, Sember QC, Arun BK. Damodaran S, et al. Breast J. 2020 Aug;26(8):1565-1571. doi: 10.1111/tbj.13966. Epub 2020 Jul 22. Breast J. 2020. PMID: 32696498

7

PARP Inhibitors in Triple-Negative Breast Cancer Including Those With BRCA Mutations.

Layman RM, Arun B. Layman RM, et al. Among authors: arun b. Cancer J. 2021 Jan-Feb 01;27(1):67-75. doi: 10.1097/PPO.0000000000000499. Cancer J. 2021. PMID: 33475295 Review.

8

PARP Inhibitor Upregulates PD-L1 Expression and Enhances Cancer-Associated Immunosuppression.

Jiao S, Xia W, Yamaguchi H, Wei Y, Chen MK, Hsu JM, Hsu JL, Yu WH, Du Y, Lee HH, Li CW, Chou CK, Lim SO, Chang SS, Litton J, Arun B, Hortobagyi GN, Hung MC. Jiao S, et al. Among authors: arun b. Clin Cancer Res. 2017 Jul 15;23(14):3711-3720. doi: 10.1158/1078-0432.CCR-16-3215. Epub 2017 Feb 6. Clin Cancer Res. 2017. PMID: 28167507 Free PMC article.

9

Systemic Treatment Strategies for Patients with Hereditary Breast Cancer Syndromes.

Parkes A, Arun BK, Litton JK. Parkes A, et al. Oncologist. 2017 Jun;22(6):655-666. doi: 10.1634/theoncologist.2016-0430. Epub 2017 May 3. Oncologist. 2017. PMID: 28469042 Free PMC article. Review.

10

Association Between Plasma Diacetylspermine and Tumor Spermine Synthase With Outcome in Triple-Negative Breast Cancer.

Fahrmann JF, Vykoukal J, Fleury A, Tripathi S, Dennison JB, Murage E, Wang P, Yu CY, Capello M, Creighton CJ, Do KA, Long JP, Irajizad E, Peterson C, Katayama H, Disis ML, Arun B, Hanash S. Fahrmann JF, et al. Among authors: arun b. J Natl Cancer Inst. 2020 Jun 1;112(6):607-616. doi: 10.1093/jnci/djz182. J Natl Cancer Inst. 2020. PMID: 31503278 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

411 results

Search Page

Filters